Asia Pacific Poultry Vaccines Market

The Asia Pacific poultry vaccines market was valued at US$ 752.66 million in 2023 and is expected to reach US$ 1,514.33 million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Boost Asia Pacific Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

•  In December 2022, the Indian Government announced launching of schemes such as the "Livestock Health & Disease Control Scheme" improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers "research & innovation, publicity & awareness, training & allied activities" that are 100% Center-funded.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

Asia Pacific Poultry Vaccines Market Overview

The Asia Pacific poultry vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to grow considerably owing to factors such as the increasing incidences of livestock diseases, the rising incidences of zoonotic diseases, the presence of leading players, and initiatives taken by various government agencies and animal associations. Further, developing healthcare infrastructure and increasing per capita animal healthcare expenditure are projected to drive the Asia Pacific poultry vaccines market during the forecast period.

Asia Pacific Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

 

Get more information on this report Request Free Sample PDF

Asia Pacific Poultry Vaccines Strategic Insights

Strategic insights for the Asia Pacific Poultry Vaccines provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Poultry Vaccines Report Scope

Asia Pacific Poultry Vaccines Regional Insights

The geographic scope of the Asia Pacific Poultry Vaccines refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Poultry Vaccines Market Segmentation

The Asia Pacific poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Asia Pacific poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Asia Pacific poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Asia Pacific poultry vaccines market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB. are some of the leading companies operating in the Asia Pacific poultry vaccines market.